We use cookies for a better user experience. Read our Privacy Policy

I Agree

Particle Therapy Market

Particle Therapy Market (Therapy: Proton Therapy and Heavy Ion Therapy; Service: Cyclotrons, Synchrotrons, and Synchrocyclotrons) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Particle Therapy Market Outlook 2031

  • The global particle therapy market was valued at US$ 560.3 Mn in 2021
  • The global market is projected to expand at a CAGR of 8.6% from 2022 to 2031
  • The global particle therapy market is anticipated to exceed the value of US$ 1.2 Bn by 2031

Analysts’ Viewpoint on Particle Therapy Market Scenario

The global particle therapy market is expected to be driven by rise in prevalence of cancer, low risk of treatment-induced disorders, and increase in the number of particle therapy centers across the world. The primary goal of the proton therapy is to improve radiation therapy by using proton beams for the treatment of localized tumors and radiosurgery. Particle therapy is a type of radiotherapy. Its beam speed can be adjusted based on the depth of the treatment site, allowing it to deliver a concentrated dose of radiation to the cancer patient. Benefits of the particle therapy in specific clinical situations have been confirmed by rise in the number of trials, and advancements in beam delivery, image guidance, and treatment planning are expected during the forecast period. Moreover, positive clinical results have led to an increase in the number of treatment facilities across the world of which, several are in the planning stage or under construction.

particle therapy market

Particle Therapy Sparks Social Innovations for Improving Cancer Patient Outcomes

Particle therapy is also known as the radiation therapy that uses streams of protons that are tiny particles with a positive charge to kill tumor cells. Healthcare providers are increasingly making available different types of particle therapy for cancers such as heavy ion therapy and proton therapy (PT). Non-invasive nature and reduced side effects of proton therapy systems are being preferred for the treatment of bladder cancer in patients.

In order to increase patient outcomes, companies in the particle therapy market are turning challenging collaboration projects and concepts into solutions that serve social innovation. Leading research and care institutes are joining forces to advance in innovations for radiotherapy. Technological developments in cyclotron machines are one of the important strategies that are underway for the treatment of cancer patient.

Request a sample to get extensive insights into the Particle Therapy Market

Cancer Care Centers Adapting to Rigid Safety Protocols amid COVID-19 Pandemic

The COVID-19 pandemic has potentially slowed the progress of paradigm-changing innovations in particle that could improve the lives of future generations. Nevertheless, companies in the particle therapy market are adapting to the new normal by continuing care services for high-risk and vulnerable cancer patients.

Cancer care facilities are implementing rigid safety protocols and adaptations for the patients & staff. In order to ensure the adherence to safety protocols, cancer care centers are instituting many precautions that include daily screenings of every staff member, patient, and visitor to the center. In addition, rise of telemedicine and remote patient monitoring would likely become one of the defining influences of the pandemic on the global healthcare industry.

High Cost and Technological Challenges Inhibiting Growth of Particle Therapy Market

The global particle therapy market is projected to advance at a robust CAGR throughout the assessment period. However, lack of evidence about clinical outcomes, high cost of therapy, and radiobiological uncertainties are hampering its widespread adoption among cancer patients. Hence, companies in the particle therapy market are increasing R&D to overcome technological challenges and increasing efforts to integrate technical developments into particle therapy systems.

Companies in the particle therapy market are conducting research studies to continuously improve the efficiency of proton therapy systems, in terms of technology and delivery technics & cost. Significant developments are being made in terms of conformation of the dose to the target and transport & spatial resolution achievable with pencil beam scanning.

Different Cancer Types Fueling Demand for Proton Therapy

There is a growing demand for proton therapy for the treatment of breast cancer, brain tumor, and pediatric cancer. There is a high prevalence of inflammatory breast cancer, triple negative breast cancer, and invasive ductal carcinoma breast cancer globally.

The proton therapy is also being used in the treatment of patients with benign tumors, tumors near sensitive areas of the brain, and patients who have recurrent brain tumors following treatment.

In addition, advantages of photon-beam radiotherapy are being extended for the treatment of pediatric cancer, since this treatment method is found to limit the radiation exposure to healthy and growing tissue in children, adolescents, and young adults.

Lucrative Market Expansion Opportunities in India and Italy

An alarmingly high number of cancer cases in India and Italy have compelled healthcare companies in the particle therapy market to invest in state-of-the-art facilities. These facilities are accommodating the hadron therapy, as a part of their care services profile.

The possibility to treat radio-resistant tumors, precision treatment, and suitability for the treatment of brain, skull, and spinal cord is increasing the popularity of hadron therapy among patients. Head, neck, and upper respiratory tract tumors are being treated with the help of the hadron therapy.

Request a custom report on Particle Therapy Market

Particle Therapy Market: Overview

  • Increase in adoption of particle therapy along with advantages such as high precision, shorter treatment duration, and lower side-effects compared to conventional photon therapies using X-rays are expected to drive the global particle therapy market from 2022 to 2031
  • Surge in investment in cancer research is likely to fuel the growth of the particle therapy market during the forecast period. Moreover, rise in adoption of various particle therapy products by hospitals and clinics is projected to propel the global market from 2022 to 2031.

Rise in Adoption of Particle Therapy in Clinical Trials to Drive Global Market

  • Interest in proton beam therapy (PBT) has increased in the past few years. The physical properties of charged particle therapy enable superior dose distribution. Hence, PBT offers potential opportunities to reduce toxicity and increase tumor control. The number of cancer surgical procedures has increased in the past few years. Hence, the adoption rate of particle therapy is rising to treat the after effects of cancer surgery.

Increase in Application of Proton Therapy to Treat Cancer

  • The proton therapy segment held major share of the global market in terms of revenue in 2021. The segment is anticipated to reach US$ 1,063.0 Mn by 2031. Increase in applications of proton therapy to treat several cancers such as brain tumor, breast cancer, pediatric cancer, head and neck cancer, and other noncancerous tumors is expected to drive global particle therapy market during forecast period. Due to the unique physical properties of protons, doctors are able to deliver radiation to a specific depth in the body. Hence, proton therapy is more effective than heavy ion therapy.
  • Presently, proton therapy is used to treat different types of cancer, and it is especially useful in situations where treatment options are limited and conventional photon-beam radiotherapy poses unacceptable risks to patients. It is also useful when treating brain and spinal cord tumors in children, who frequently suffer long-term side effects from toxic cancer treatments.

Brain & Spinal Cord Tumors (BSCT) Segment to Lead Global Particle Therapy Market

  • The brain & spinal cord segment was valued at US$ 117 Mn in 2021 and is set to expand at the fastest CAGR from 2022 to 2031
particle therapy market share
  • Particle therapy is primarily used to treat head & neck cancer and pediatric cancers. It is also used to treat spine tumors, breast cancer, sarcoma, brain tumors, and prostate cancer. The brain & spinal cord tumors (BSCT) segment is expected to account for major share of the global particle therapy market during the forecast period. Limiting radiation doses to other critical structures such as the brain stem, spinal cord, and healthy brain tissue that control important body functions is critical when treating brain & other central nervous system cancers.
  • Advantages over non-small cell lung cancer (NSCLC) treatment and rise in awareness about the use of particle therapy for lung cancer treatment are likely to propel the segment during the forecast period.

Rise in Use of Cyclotrons

  • The cyclotrons segment is projected to drive the global particle therapy market from 2022 to 2031. The cyclotrons segment accounted for the largest share of 60% of the global market in 2021.
  • A cyclotron is an important piece of technology for proton therapy, which uses an aimed beam of protons directed at a tumor site to treat various cancers. Proton beam therapy uses specialized machines, the most common of which are cyclotrons, to generate and accelerate protons to speeds of up to 60% the speed of light and energies of up to 250 million electron volts.

Hospitals Segment to Lead Global Particle Therapy Market

  • The hospitals segment led the global particle therapy market in 2021. The segment is anticipated to account for 67.9% share of the market by 2031. The hospitals segment is expected to expand at a CAGR of 9.0% from 2022 to 2031.
  • Proton therapy is available in several hospital-based facilities, many of which are built and supported by commercial vendors

North America to Dominate Global Particle Therapy Market

  • North America dominated the global particle therapy market in 2021. The market in the region is anticipated to expand at a CAGR of 7.6% from 2022 to 2031. Growth of the market in North America can be attributed to early adoption of innovative medicated treatment and availability of larger number of particle therapy centers.
particle therapy market cagr
  • According to the National Association for Proton Therapy, proton therapy is the most frequently used particle therapy in the U.S., and over 75,000 patients have been treated with proton therapy. Moreover, the U.S. has 38 centers providing proton therapy. Hence, North America is expected to account for major share of the global market during the forecast period.
  • Europe is expected to be the fastest growing market for particle therapy from 2022 to 2031. Availability of technologically advanced platforms for the diagnosis of disorders, increase in incidence of cancer, large number of distribution channels, and launch of innovative & advanced technologies by major manufacturers are likely to augment the market in the region during the forecast period. Germany dominated the market in Europe in 2021. The market in Germany is projected to grow at a rapid pace from 2022 to 2031.
  • Asia Pacific is one of the leading markets for particle therapy due to rise in prevalence of cancer and increase in number of radiotherapy procedures

Major Players in Particle Therapy Market

  • The particle therapy market report concludes with the company profiles section, which includes key information about major players in the global particle therapy market
  • Leading players analyzed in the report include
    • Advanced Oncotherapy plc
    • Danfysik A/S
    • Hitachi, Ltd.
    • IBA Worldwide
    • Mevion Medical Systems, Inc.
    • Optivus Proton Therapy, Inc.
    • ProTom International, Inc.
    • Provision Healthcare
    • Sumitomo Heavy Industries, Ltd.
    • Varian Medical Systems, Inc
    • Other prominent players
  • Each of these players has been profiled in the particle therapy market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Particle Therapy Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 560.3 Mn

Market Forecast Value in 2031

US$ 1,267.16 Mn

Growth Rate (CAGR)

8.6% from Year-to-Year

Forecast Period

2022–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Therapy
    • Proton Therapy
    • Heavy Ion Therapy
  • Application
    • Pediatric Cancer
    • Lung Cancer
    • Bladder Cancer
    • Brain & Spinal Cord Tumors (BSCT)
    • Breast Cancer
    • Gastrointestinal (GI) Cancers
    • Hepatocellular Carcinoma (HCC)
    • Head & Neck Cancers (HNC)
    • Others
  • Service
    • Cyclotrons
    • Synchrotrons
    • Synchrocyclotrons
  • End-user
    • Hospitals
    • Academic & Research Centers

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand

Companies Profiled

  • Advanced Oncotherapy plc
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.
  • Optivus Proton Therapy, Inc.
  • ProTom International, Inc.
  • Provision Healthcare
  • Sumitomo Heavy Industries, Ltd.
  • Varian Medical Systems, Inc.
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Particle Therapy Market – Segmentation

TMR’s study on the global particle therapy market includes information divided into five segments: therapy, application, service, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global particle therapy market are discussed in detail.

Therapy
  • Proton Therapy
  • Heavy Ion Therapy
Application
  • Pediatric Cancer
  • Lung Cancer
  • Bladder Cancer
  • Brain & Spinal Cord Tumors (BSCT)
  • Breast Cancer
  • Gastrointestinal (GI) Cancers
  • Hepatocellular Carcinoma (HCC)
  • Head & Neck Cancers (HNC)
  • Others
Service
  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotrons
End-user
  • Hospitals
  • Academic & Research Centers
Region
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Note: Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights.

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total worth of the particle therapy market?

Particle therapy market was valued at US$ 560.3 Mn in 2021 and expected to exceed US$ 1.2 Bn by 2031

What is the anticipated CAGR of the particle therapy market?

Particle Therapy market is expected to grow at a CAGR of 9% during the forecast period

What are the major drivers for the particle therapy market?

Increase in number of cancer patients and rise in adoption of particle therapy in clinical trials are projected to drive this market

Which regional market is set to expand at the fastest CAGR during the forecast period?

The particle therapy market in Europe is likely to expand at the fastest CAGR during the forecast period

Which segment is expected to lead the particle therapy market in 2031?

The proton therapy segment is likely to generate highest revenue in 2031

Who are the key payers operating in the global market?

Varian Medical Systems, Inc. (Siemens Healthineers AG), Hitachi, Ltd., and IBA Worldwide are prominent players in the global market

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Particle Therapy Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Particle Therapy Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Reimbursement Scenario

    5.3. Particle Therapy Facilities In Clinical Operation, 2021

    5.4. Average Prices, by Region, 2021

    5.5. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Particle Therapy Market Analysis and Forecast, By Therapy

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Therapy, 2017–2031

        6.3.1. Proton Therapy

        6.3.2. Heavy Ion Therapy (carbon therapy, He, pion)

    6.4. Market Attractiveness Analysis, By Therapy

7. Global Particle Therapy Market Analysis and Forecast, By Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Pediatric Cancer

        7.3.2. Lung Cancer

        7.3.3. Bladder Cancer

        7.3.4. Brain & Spinal Cord Tumors (BSCT)

        7.3.5. Breast Cancer

        7.3.6. Gastrointestinal (GI) Cancers

        7.3.7. Hepatocellular Carcinoma (HCC)

        7.3.8. Head & Neck Cancers (HNC)

        7.3.9. Others

    7.4. Market Attractiveness Analysis, By Application

8. Global Particle Therapy Market Analysis and Forecast, By Service

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Service, 2017–2031

        8.3.1. Cyclotrons

        8.3.2. Synchrotrons

        8.3.3. Synchrocyclotrons

    8.4. Market Attractiveness Analysis, By Service

9. Global Particle Therapy Market Analysis and Forecast, By End-user

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Hospitals

        9.3.2. Academic & Research Centers

    9.4. Market Attractiveness Analysis, By End-user

10. Global Particle Therapy Market Analysis and Forecast, By Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Rest of the World

    10.3. Market Attractiveness Analysis, By Region

11. North America Particle Therapy Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Therapy, 2017–2031

        11.2.1. Proton Therapy

        11.2.2. Heavy Ion Therapy (carbon therapy, He, pion)

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Pediatric Cancer

        11.3.2. Lung Cancer

        11.3.3. Bladder Cancer

        11.3.4. Brain & Spinal Cord Tumors (BSCT)

        11.3.5. Breast Cancer

        11.3.6. Gastrointestinal (GI) Cancers

        11.3.7. Hepatocellular Carcinoma (HCC)

        11.3.8. Head & Neck Cancers (HNC)

        11.3.9. Others

    11.4. Market Value Forecast, by Service, 2017–2031

        11.4.1. Cyclotrons

        11.4.2. Synchrotrons

        11.4.3. Synchrocyclotrons

    11.5. Market Value Forecast, by End-user, 2017–2031

        11.5.1. Hospitals

        11.5.2. Academic & Research Centers

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Therapy

        11.7.2. By Application

        11.7.3. By Service

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Particle Therapy Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Therapy, 2017–2031

        12.2.1. Proton Therapy

        12.2.2. Heavy Ion Therapy (carbon therapy, He, pion)

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Pediatric Cancer

        12.3.2. Lung Cancer

        12.3.3. Bladder Cancer

        12.3.4. Brain & Spinal Cord Tumors (BSCT)

        12.3.5. Breast Cancer

        12.3.6. Gastrointestinal (GI) Cancers

        12.3.7. Hepatocellular Carcinoma (HCC)

        12.3.8. Head & Neck Cancers (HNC)

        12.3.9. Others

    12.4. Market Value Forecast, by Service, 2017–2031

        12.4.1. Cyclotrons

        12.4.2. Synchrotrons

        12.4.3. Synchrocyclotrons

    12.5. Market Value Forecast, by End-user, 2017–2031

        12.5.1. Hospitals

        12.5.2. Academic & Research Centers

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Therapy

        12.7.2. By Application

        12.7.3. By Service

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Particle Therapy Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Therapy, 2017–2031

        13.2.1. Proton Therapy

        13.2.2. Heavy Ion Therapy (carbon therapy, He, pion)

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Pediatric Cancer

        13.3.2. Lung Cancer

        13.3.3. Bladder Cancer

        13.3.4. Brain & Spinal Cord Tumors (BSCT)

        13.3.5. Breast Cancer

        13.3.6. Gastrointestinal (GI) Cancers

        13.3.7. Hepatocellular Carcinoma (HCC)

        13.3.8. Head & Neck Cancers (HNC)

        13.3.9. Others

    13.4. Market Value Forecast, by Service, 2017–2031

        13.4.1. Cyclotrons

        13.4.2. Synchrotrons

        13.4.3. Synchrocyclotrons

    13.5. Market Value Forecast, by End-user, 2017–2031

        13.5.1. Hospitals

        13.5.2. Academic & Research Centers

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Therapy

        13.7.2. By Application

        13.7.3. By Service

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Rest of the World Particle Therapy Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Therapy, 2017–2031

        14.2.1. Proton Therapy

        14.2.2. Heavy Ion Therapy (carbon therapy, He, pion)

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Pediatric Cancer

        14.3.2. Lung Cancer

        14.3.3. Bladder Cancer

        14.3.4. Brain & Spinal Cord Tumors (BSCT)

        14.3.5. Breast Cancer

        14.3.6. Gastrointestinal (GI) Cancers

        14.3.7. Hepatocellular Carcinoma (HCC)

        14.3.8. Head & Neck Cancers (HNC)

        14.3.9. Others

    14.4. Market Value Forecast, by Service, 2017–2031

        14.4.1. Cyclotrons

        14.4.2. Synchrotrons

        14.4.3. Synchrocyclotrons

    14.5. Market Value Forecast, by End-user, 2017–2031

        14.5.1. Hospitals

        14.5.2. Academic & Research Centers

    14.6. Market Attractiveness Analysis

        14.6.1. By Therapy

        14.6.2. By Application

        14.6.3. By Service

        14.6.4. By End-user

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2020

    15.3. Company Profiles

        15.3.1. Advanced Oncotherapy plc

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Strategic Overview

        15.3.2. Danfysik A/S

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Strategic Overview

        15.3.3. Hitachi, Ltd.

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Strategic Overview

        15.3.4. IBA Worldwide

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Strategic Overview

        15.3.5. Mevion Medical Systems, Inc.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Strategic Overview

        15.3.6. Optivus Proton Therapy, Inc.

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Strategic Overview

        15.3.7. Protom International, Inc.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Strategic Overview

        15.3.8. Provision Healthcare

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Strategic Overview

        15.3.9. Sumitomo Heavy Industries, Ltd.

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Strategic Overview

        15.3.10. Varian Medical Systems, Inc.

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Strategic Overview

List of Tables

Table 01: Global Particle Therapy Market Value (US$ Mn) Forecast, by Therapy 2017–2031

Table 02: Global Particle Therapy Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 03: Global Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017‒2031

Table 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America Particle Therapy Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 08: North America Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031

Table 09: North America Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 10: North America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 13: Europe Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031

Table 14: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 15: Europe Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 18: Asia Pacific Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 20: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

Table 22: Rest of the World Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031

Table 23: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 24: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Particle Therapy market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 03: Global Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by Proton Therapy, 2017–2031

Figure 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Heavy Ion Therapy, 2017–2031

Figure 06: Global Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031

Figure 07: Global Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 08: Global Particle Therapy Market Value (US$ Mn) Forecast, by Pediatric Cancer, 2017–2031

Figure 09: Global Particle Therapy Market Value (US$ Mn) Forecast, by Lung Cancer, 2017–2031

Figure 10: Global Particle Therapy Market Value (US$ Mn) Forecast, by Bladder Cancer, 2017–2031

Figure 11: Global Particle Therapy Market Value (US$ Mn) Forecast, by Brain &Spinal Cord Tumors, 2017–2031

Figure 12: Global Particle Therapy Market Value (US$ Mn) Forecast, by Breast Cancer, 2017–2031

Figure 13: Global Particle Therapy Market Value (US$ Mn) Forecast, by Gastrointestinal (GI) Cancers, 2017–2031

Figure 14: Global Particle Therapy Market Value (US$ Mn) Forecast, by Hepatocellular Carcinoma (HCC), 2017–2031

Figure 15: Global Particle Therapy Market Value (US$ Mn) Forecast, by Head & Neck Cancers (HNC), 2017–2031

Figure 16: Global Particle Therapy Market Value (US$ Mn) Forecast, by Other Cancers, 2017–2031

Figure 17: Global Particle Therapy Market, by Service, 2021 and 2031

Figure 18: Global Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031

Figure 19: Global Particle Therapy Market Value (US$ Mn) Forecast, by Cyclotrons, 2017–2031

Figure 20: Global Particle Therapy Market Value (US$ Mn) Forecast, by Synchrotrons, 2017–2031

Figure 21: Global Particle Therapy Market Value (US$ Mn) Forecast, by Synchrocyclotrons, 2017–2031

Figure 22: Global Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 23: Global Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 24: Global Particle Therapy Market (US$ Mn), by Hospitals, 2017–2031

Figure 25: Global Particle Therapy Market (US$ Mn), by Academic & Research Institutes, 2017–2031

Figure 26: Global Particle Therapy Market Value Share Analysis, by Region, 2021 and 2031

Figure 27: Global Particle Therapy Market Attractiveness Analysis, by Region, 2022–2031

Figure 28: North America Particle Therapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 29: North America Particle Therapy Market Value Share Analysis, by Country, 2021 and 2031

Figure 30: North America Particle Therapy Market Attractiveness Analysis, by Country, 2022–2031 

Figure 31: North America Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 32: North America Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 33: North America Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031

Figure 34: North America Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 35: North America Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031

Figure 36: North America Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031

Figure 37: North America Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 38: North America Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 39: Europe Particle Therapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 40: Europe Particle Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 41: Europe Particle Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

Figure 42: Europe Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 43: Europe Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 44: Europe Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031

Figure 45: Europe Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 46: Europe Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031

Figure 47: Europe Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031

Figure 48: Europe Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 49: Europe Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 50: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 51: Asia Pacific Particle Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 52: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

Figure 53: Asia Pacific Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 54: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 55: Asia Pacific Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031

Figure 56: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 57: Asia Pacific Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031

Figure 58: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031

Figure 59: Asia Pacific Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 60: Asia Pacific Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 61: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 62: Rest of the World Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 63: Rest of the World Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 64: Rest of the World Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031

Figure 65: Rest of the World Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031

Figure 66: Rest of the World Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031

Figure 67: Rest of the World Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031

Figure 68: Rest of the World Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 69: Rest of the World Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

113

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved